Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11738)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2016 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol 2016; 22(34): 7645-7659 [PMID: 27678348 DOI: 10.3748/wjg.v22.i34.7645] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i34/7645.htm |
| Number | Citing Articles |
| 1 |
Zhixin Wang, Kai Qu, Lei Zhou, Li Ren, Bin Ren, Fandi Meng, Wenhao Yu, Haijiu Wang, Haining Fan. Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 2021; 577: 45 doi: 10.1016/j.bbrc.2021.08.030
|
| 2 |
Guolin Chen, Shanshan Mo, Di Yuan, Tao Huang. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9911784
|
| 3 |
Zheyuan Wang, Zhiheng Shi, Lu Zhang, Huihan Zhang, Yawu Zhang. Profilin 1, negatively regulated by microRNA-19a-3p, serves as a tumor suppressor in human hepatocellular carcinoma. Pathology - Research and Practice 2019; 215(3): 499 doi: 10.1016/j.prp.2018.12.012
|
| 4 |
Muntadher Jihad, İdil Yet. Multiomics Integration at Single-Cell Resolution Using Bayesian Networks: A Case Study in Hepatocellular Carcinoma. OMICS: A Journal of Integrative Biology 2023; 27(1): 24 doi: 10.1089/omi.2022.0170
|
| 5 |
Mostafa Abasseri, Shakira Hoque, Kim Caldwell, Linda Sheahan, Slavica Kochovska, Meera Agar, Amany Zekry. Exploring Misconceptions of Palliative Care Among Patients With Hepatocellular Carcinoma: A Pilot Study. American Journal of Hospice and Palliative Medicine® 2024; doi: 10.1177/10499091241268423
|
| 6 |
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
|
| 7 |
Zhe Tang, Muxing Kang, Bo Zhang, Jianke Chen, Heqing Fang, Qin Ye, Biao Jiang, Yulian Wu. Advantage of Sorafenib Combined with Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma. Tumori Journal 2017; 103(3): 286 doi: 10.5301/tj.5000585
|
| 8 |
Yan Xia, Xianhao Liu, Beibei Liu, Xiaoshi Zhang, Geng Tian. Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5905
|
| 9 |
Li-Wei Qiu, Yi-Fei Liu, Xiao-Qing Cao, Yan Wang, Xiao-Hong Cui, Xian Ye, Shuo-Wen Huang, Hong-Jun Xie, Hai-Jian Zhang. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis <i>via</i> the immune microenvironment. World Journal of Gastroenterology 2020; 26(18): 2126-2137 doi: 10.3748/wjg.v26.i18.2126
|
| 10 |
Jing Bai, Ziqi Liu, Jiang Liu, Saihang Zhang, Yuan Tian, Yueshan Zhang, Leiming Ren, Dezhi Kong. Mitochondrial metabolic study guided by proteomics analysis in hepatocellular carcinoma cells surviving long-term incubation with the highest dose of sorafenib. Aging 2019; 11(24): 12452 doi: 10.18632/aging.102582
|
| 11 |
Wenfang Xu, Wenke Guo, Ping Lu, Duan Ma, Lei Liu, Fudong Yu. Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20203231
|
| 12 |
Chaopin Yang, Jinqi You, Qiuzhong Pan, Yan Tang, Liming Cai, Yue Huang, Jiamei Gu, Yizhi Wang, Xinyi Yang, Yufei Du, Dijun Ouyang, Hao Chen, Haoran Zhong, Yongqiang Li, Jieying Yang, Yulong Han, Fengze Sun, Yuanyuan Chen, Qijing Wang, Desheng Weng, Zhongqiu Liu, Tong Xiang, Jianchuan Xia. Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma. BMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-03016-0
|
| 13 |
Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases. 2023; : 109 doi: 10.1016/B978-0-323-99136-0.00015-5
|
| 14 |
María Julia Martínez, Adriana Balbina Andreu, Luciana Barbini. Cytotoxic activity of Solanum tuberosum polyphenolic extracts in human hepatocarcinoma cells is mediated by apoptosis and autophagy. Journal of Food Science 2022; 87(12): 5303 doi: 10.1111/1750-3841.16366
|
| 15 |
Junfeng Wang, Jianying Lou, Lei Fu, Qu Jin. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment. Journal of International Medical Research 2021; 49(2) doi: 10.1177/0300060520980646
|
| 16 |
Zhi-Gang Gong, Weijie Zhao, Jianbing Zhang, Xi Wu, Jing Hu, Guo-Chang Yin, Yong-Jiang Xu. Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis. Oncotarget 2017; 8(38): 63890 doi: 10.18632/oncotarget.19173
|
| 17 |
Louie Semaan, Qingning Zeng, Yong Lu, Yi Zhang, Mehdi Mohamad Zreik, Mohamad Baqer Chamseddine, Michael Chopp, Zheng Gang Zhang, Dilip Moonka. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs. Oncotarget 2021; 12(3): 185 doi: 10.18632/oncotarget.27879
|
| 18 |
Stefano Colagrande, Linda Calistri, Giulia Grazzini, Cosimo Nardi, Simone Busoni, Giovanni Morana, Luigi Grazioli. MRI features of primary hepatic lymphoma. Abdominal Radiology 2018; 43(9): 2277 doi: 10.1007/s00261-018-1476-5
|
| 19 |
Tung-Ho Wu, Tung-Yi Lin, Pei-Ming Yang, Wen-Tai Li, Chau-Ting Yeh, Tai-Long Pan. Scutellaria baicalensis Induces Cell Apoptosis and Elicits Mesenchymal–Epithelial Transition to Alleviate Metastatic Hepatocellular Carcinoma via Modulating HSP90β. International Journal of Molecular Sciences 2024; 25(5): 3073 doi: 10.3390/ijms25053073
|
| 20 |
Bibhu Prasad Satapathy, Pooja Sheoran, Rohit Yadav, Dewan Chettri, Dhruba Sonowal, Chinmayee Priyadarsini Dash, Prachi Dhaka, Vivek Uttam, Ritu Yadav, Manju Jain, Aklank Jain. The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1389971
|
| 21 |
Carmen Berasain, André Lechel. Targeting the correct target in HCC. Gut 2017; 66(8): 1352 doi: 10.1136/gutjnl-2016-313462
|
| 22 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; : 1105 doi: 10.2147/JHC.S341195
|
| 23 |
Yusra Zarlashat, Hassan Mushtaq, Linh Pham, Wasim Abbas, Keisaku Sato. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies. International Journal of Molecular Sciences 2024; 25(13): 6830 doi: 10.3390/ijms25136830
|
| 24 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
| 25 |
Ya-Lin Kong, Jin-Jin Sun, Hong-Yi Zhang, Ying Xing, Cheng Wang, Yang Liu, Xiao-Jun He, Ling-Hong Kong, Cheng-Li Liu. Clinical evaluation of percutaneous endovascular radiofrequency ablation for portal vein tumor thrombus: experience in 120 patients. Surgical Endoscopy 2023; 37(2): 1173 doi: 10.1007/s00464-022-09639-3
|
| 26 |
Yue Ming, Bin Li, Ruoqiu Fu, Haiyan Xing, Yao Liu, Dongyu Duan, Ziwei Li, Li Li, Rui Ni, Jing Xu, Chen Li, Mingfeng Xiang, Hongyu Song, Jianhong Chen. Bovine Serum Albumin Nanoparticle-Mediated Delivery of Sorafenib for Improving Hepatocellular Carcinoma Therapy. Journal of Nanoscience and Nanotechnology 2021; 21(10): 5075 doi: 10.1166/jnn.2021.19362
|
| 27 |
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis. Transplantation Reviews 2023; 37(3): 100763 doi: 10.1016/j.trre.2023.100763
|
| 28 |
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania, María Laura Ruiz. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 2019; 26(7): 1224 doi: 10.2174/0929867325666180105103637
|
| 29 |
Beom-Hui Lee, Dong-Shik Lee, Chan Woo Cho, Sung-Su Yun. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1685-6
|
| 30 |
Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Marwa G. El-Gazzar, Mostafa G.M. El-Gazzar. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2018; 28(9): 1464 doi: 10.1016/j.bmcl.2018.03.089
|
| 31 |
Minho Noh, Beom Kyung Kim, Seung Up Kim. Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization. Journal of Liver Cancer 2021; 21(1): 97 doi: 10.17998/jlc.21.1.97
|
| 32 |
Mohammad Roshani, Arya Rezaian-Isfahni, Mohammad Hassan Lotfalizadeh, Negar Khassafi, Mohammad Hassan Jafari Najaf Abadi, Majid Nejati. Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03115-1
|
| 33 |
|
| 34 |
Dongping Li, Xiahui Lin, Jiale Li, Xinyi Liu, Feng Zhang, Wenqing Tang, Si Zhang, Ling Dong, Ruyi Xue. Eleven metabolism‑related genes composed of Stard5 predict prognosis and contribute to EMT phenotype in HCC. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03097-0
|
| 35 |
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 321 doi: 10.1002/9781119756422.ch18
|
| 36 |
Wenfang Xu, Zhen Chen, Gang Liu, Yuping Dai, Xuanfu Xu, Duan Ma, Lei Liu, John Patrick Vanden Heuvel. Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma. PPAR Research 2021; 2021: 1 doi: 10.1155/2021/6642939
|
| 37 |
Liang Peng, Rong Ye, Xiansen Zhu, Yuankang Xie, Baiyin Zhong, Yao Liu, Heping Li, Binhui Xie, Arturo Ortega. LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β-Catenin in the Nucleus to Augment Wnt Signaling. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/9631036
|
| 38 |
Kumardeep Chaudhary, Olivier B. Poirion, Liangqun Lu, Lana X. Garmire. Deep Learning–Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. Clinical Cancer Research 2018; 24(6): 1248 doi: 10.1158/1078-0432.CCR-17-0853
|
| 39 |
Cheng Jin, Ling Bai, Lemin Lin, Shuangquan Wang, Xiaolong Yin. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab’)2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46(5): 1076 doi: 10.1080/21691401.2017.1360325
|
| 40 |
Xiaofei Li, Daofu Zhang, Shan Guan, Weiwei Ye, Liwen Liu, Lianqing Lou. Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review. Oncotarget 2017; 8(54): 93179 doi: 10.18632/oncotarget.21452
|
| 41 |
Zaiba S. Dawood, Zachary J. Brown, Laura Alaimo, Henrique A. Lima, Chanza Shaikh, Erryk S. Katayama, Muhammad M. Munir, Zorays Moazzam, Yutaka Endo, Selamawit Woldesenbet, Timothy M. Pawlik. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors – a systematic review and meta-analysis. HPB 2024; 26(5): 618 doi: 10.1016/j.hpb.2024.02.003
|
| 42 |
Perry B. Hammond, Jonathan R. Mark, Rebecca R. Benefiel. Imperial Epistaxis and Edema: Insights into the Death of the Roman Emperor Hadrian. Ear, Nose & Throat Journal 2024; 103(3): 137 doi: 10.1177/01455613211042120
|
| 43 |
Zheng Dong, Ruizhao Qi, Xiaodong Guo, Xin Zhao, Yinyin Li, Zhen Zeng, Wenlin Bai, Xiujuan Chang, Liyan Hao, Yan Chen, Min Lou, Zhiwei Li, Yinying Lu. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation. Biochemical and Biophysical Research Communications 2017; 483(1): 630 doi: 10.1016/j.bbrc.2016.12.091
|
| 44 |
Tsinat Berhane, Anja Holm, Kasper Thystrup Karstensen, Andreas Petri, Mirolyuba Simeonova Ilieva, Henrik Krarup, Mogens Vyberg, Marianne Bengtson Løvendorf, Sakari Kauppinen. Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicin. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23802-9
|
| 45 |
Tsvetelina Velikova, Milena Gulinac. Urgent need for prognostic markers for hepatocellular carcinoma in the light of genomic instability and non-coding RNA signatures. World Journal of Gastrointestinal Surgery 2024; 16(10): 3087-3090 doi: 10.4240/wjgs.v16.i10.3087
|
| 46 |
Weijian Sun, Bin He, Beng Yang, Wendi Hu, Shaobing Cheng, Heng Xiao, Zhengjie Yang, Xiaoyu Wen, Lin Zhou, Haiyang Xie, Xian Shen, Jian Wu, Shusen Zheng. Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma. Laboratory Investigation 2018; 98(6): 734 doi: 10.1038/s41374-018-0027-6
|
| 47 |
Amr M. Shugaa Addin, Randa M. Talaat, Moustafa A. Sakr, Manal O. El Hamshary, Mohamed K. Khalifa, Ghada M. Nasr. Identification of the somatic mutations of SMAD4 among HCC Egyptian patients using NGS. Gene Reports 2022; 26: 101478 doi: 10.1016/j.genrep.2021.101478
|
| 48 |
Jean-Frédéric Blanc, Caroline Laurendeau, Marie de Zélicourt, Manel Dhaoui, Nadia Kelkouli, Francis Fagnani, Philippe Mathurin, Benjamin Chan. Treatment Patterns and Survival in Patients with Intermediate, Advanced, or Terminal Stage of Hepatocellular Carcinoma in France over the Period 2015-2017: A Real-Life Study. GastroHep 2023; 2023: 1 doi: 10.1155/2023/5800168
|
| 49 |
Sulaiman S. Alhudaithi, Mohd Abul Kalam, Lama Binobaid, Raisuddin Ali, Mohammed M. Almutairi, Wajhul Qamar, Hessa Bin Hithlayn, Atheer Almutairi, Abdullah K. Alshememry. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line. Saudi Pharmaceutical Journal 2024; 32(5): 102064 doi: 10.1016/j.jsps.2024.102064
|
| 50 |
S. Colagrande, L. Calistri, C. Campani, G. Dragoni, C. Lorini, C. Nardi, A. Castellani, F. Marra. CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib. European Radiology 2021; 31(3): 1608 doi: 10.1007/s00330-020-07171-3
|
| 51 |
Tingze Feng, Tianzhi Wu, Yanxia Zhang, Lang Zhou, Shanshan Liu, Lin Li, Ming Li, Erqiang Hu, Qianwen Wang, Xiaocong Fu, Li Zhan, Zijing Xie, Wenqin Xie, Xianying Huang, Xuan Shang, Guangchuang Yu. Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.912694
|
| 52 |
M. S. Chesnokov, O. M. Krivtsova, P. A. Skovorodnikova, A. S. Makarova, I. F. Kustova, M. D. Logacheva, A. A. Penin, A. V. Klepikova, D. A. Shavochkina, N. E. Kudashkin, E. A. Moroz, Y. I. Patyutko, E. A. Kotelnikova, N. L. Lazarevich. Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma. Biopolymers and Cell 2016; 32(6): 418 doi: 10.7124/bc.000939
|
| 53 |
Ayana R Kumar, Anitha L, Bhagyalakshmi Nair, Bijo Mathew, Sinoy Sugunan, Lekshmi R. Nath. Decoding the Mechanism of Drugs of Heterocyclic Nature against Hepatocellular
Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 2023; 23(8): 882 doi: 10.2174/1871520622666220418115310
|
| 54 |
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, Josephine Diony Nanda, Ageng Brahmadhi, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance. International Journal of Molecular Sciences 2021; 22(4): 1931 doi: 10.3390/ijms22041931
|
| 55 |
Xinlun Dai, Shupeng Wang, Chunyuan Niu, Bai Ji, Yahui Liu. Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820947486
|
| 56 |
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
|
| 57 |
Ginny Jacobs, Deborah A. Boyle, Hashem B. El‐Serag, Robert J. Lewandowski, Stacey M. Stein, Patrice Lazure, Pam McFadden. Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals. Cancer Medicine 2023; 12(3): 3670 doi: 10.1002/cam4.5216
|
| 58 |
Yasi Pan, Huarong Chen, Jun Yu. Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives. Biomedicines 2020; 8(12): 576 doi: 10.3390/biomedicines8120576
|
| 59 |
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Wen-Jing Goh, Mingliang You, Siddaiah Chandra Nayak, Lu Chen, Gautam Sethi, Kanchugarakoppal Subbegowda Rangappa, Lingzhi Wang. Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities. Cancer and Metastasis Reviews 2023; 42(3): 741 doi: 10.1007/s10555-022-10071-1
|
| 60 |
Shen Hu, Yan Zhu, Xiangyang Xia, Xiaobo Xu, Fen Chen, Xudong Miao, Xinmei Chen. Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/3815786
|
| 61 |
Mohammad Ashraful Alam, Sheikh Mohammad Noor-E-Alam, Md Abdur Rahim, Faiz Ahmad Khondaker, Ahmed Lutful Moben, Jhumur Ghosh, Md Sakirul Islam Khan. Treatment by Transarterial Chemoembolization and Sorafenib for Hepatocellular Carcinoma vs Advanced Hepatocellular Carcinoma in Bangladesh: A Real-life Situation
. Euroasian Journal of Hepato-Gastroenterology 2019; 9(2): 63 doi: 10.5005/jp-journals-10018-1300
|
| 62 |
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
|
| 63 |
Yan Zhou, Lijuan Liu, Youyi Liu, Ping Zhou, Qiujin Yan, Honglian Yu, Xiaobei Chen, Fan Zhu. Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK/ERK-mediated metastatic invasiveness and doxorubicin resistance. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00562-5
|
| 64 |
Zhou-wei Xu, Shang-xue Yan, Hua-xun Wu, Ying Zhang, Wei Wei. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression. Digestive and Liver Disease 2019; 51(2): 263 doi: 10.1016/j.dld.2018.06.007
|
| 65 |
Yuqian Mo, Zhilin Zou, Erbao Chen. Targeting ferroptosis in hepatocellular carcinoma. Hepatology International 2024; 18(1): 32 doi: 10.1007/s12072-023-10593-y
|
| 66 |
Weibo Du, Wenbiao Chen, Zheyue Shu, Dairong Xiang, Kefan Bi, Yingfeng Lu, Xujun Zhang, Lanjuan Li, Hongyan Diao. Identification of Prognostic Biomarkers of Hepatocellular Carcinoma Via Long Noncoding RNA Expression and Copy Number Alterations. Epigenomics 2020; 12(15): 1303 doi: 10.2217/epi-2019-0385
|
| 67 |
Pei-Yi Chu, Shiao-Lin Tung, Kuo-Wang Tsai, Fang-Ping Shen, Shih-Hsuan Chan. Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular Carcinoma. Cancers 2020; 12(7): 1843 doi: 10.3390/cancers12071843
|
| 68 |
Amanpreet Brar, Alice Zhu, Cristina Baciu, Divya Sharma, Wei Xu, Ani Orchanian‐Cheff, Bo Wang, Jüri Reimand, Robert Grant, Mamatha Bhat. Development of diagnostic and prognostic molecular biomarkers in hepatocellular carcinoma using machine learning: A systematic review. Liver Cancer International 2022; 3(4): 141 doi: 10.1002/lci2.66
|
| 69 |
Marta Campos, Isabel Candelária, Nickolas Papanikolaou, Adélia Simão, Carlos Ferreira, Georgios C. Manikis, Filipe Caseiro-Alves. Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study. GE - Portuguese Journal of Gastroenterology 2019; 26(4): 260 doi: 10.1159/000493351
|
| 70 |
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, Hajer Ben Khadhra, Philippe Merle, Giuliana Amaddeo, Nathalie Ganne-Carrie, Christine Silvain, Jean-Marie Peron, Philippe Mathurin, Rodolphe Anty, Thomas Uguen, Thomas Decaens, Ghassan Riachi, Mohamed Bouattour, Aurore Baron, Jean-Pierre Bronowicki, Georges-Philippe Pageaux, Olivier Rosmorduc, Gérard Ducournau, Mélina Gilberg, Alexandre Tanang, Julien Dupin, Anika Gilbert-Marceau, Jean-Frédéric Blanc. Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1168 doi: 10.1097/MEG.0000000000002546
|
| 71 |
Yao Wang, Meixia Chen, Zhiqiang Wu, Chuan Tong, Hanren Dai, Yelei Guo, Yang Liu, Jianhua Huang, Haiyan Lv, Can Luo, Kai-chao Feng, Qing-ming Yang, Xiao-lei Li, Weidong Han. CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. OncoImmunology 2018; 7(7): e1440169 doi: 10.1080/2162402X.2018.1440169
|
| 72 |
Gautham Ramesh, Shubhankar Das, Satish Rao Bola Sadashiva. Berberine, a natural alkaloid sensitizes human hepatocarcinoma to ionizing radiation by blocking autophagy and cell cycle arrest resulting in senescence. Journal of Pharmacy and Pharmacology 2020; 72(12): 1893 doi: 10.1111/jphp.13354
|
| 73 |
Jing Du, Ye Mao, Ming Liu, Yan Tie, Hai Huang, Jian Zhao, Zhongzheng Xiang, Di Luo. Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(60): 102413 doi: 10.18632/oncotarget.22061
|
| 74 |
Haibei Xin, Yuanfeng Li, Quanlei Wang, Ren Liu, Cunzhen Zhang, Haidong Zhang, Xian Su, Bin Bai, Nan Li, Minfeng Zhang. A novel risk scoring system predicts overall survival of hepatocellular carcinoma using cox proportional hazards machine learning method. Computers in Biology and Medicine 2024; 178: 108663 doi: 10.1016/j.compbiomed.2024.108663
|
| 75 |
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysis. Carcinogenesis 2020; 41(12): 1682 doi: 10.1093/carcin/bgaa106
|
| 76 |
Yang Liu, Xiang Wang, Xingzhi Zeng, Yinghua Wu, Xinrong Liu, Juan Tan, Xiaoyan Li. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation. Open Medicine 2022; 17(1): 1183 doi: 10.1515/med-2022-0510
|
| 77 |
Gillian M. Keating. Sorafenib: A Review in Hepatocellular Carcinoma. Targeted Oncology 2017; 12(2): 243 doi: 10.1007/s11523-017-0484-7
|
| 78 |
Xinyu Gu, Jun Guan, Jia Xu, Qiuxian Zheng, Chao Chen, Qin Yang, Chunhong Huang, Gang Wang, Haibo Zhou, Zhi Chen, Haihong Zhu. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-020-02691-4
|
| 79 |
Feng Wang, Jun Wang, Linlin Ju, Lin Chen, Weihua Cai, Jialin Yang. Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(5): 576 doi: 10.1177/0004563218755815
|
| 80 |
Debnarayan Dutta, Sreenija Yarlagadda, Sruthi Kalavagunta, Haridas Nair, Ajay Sasidharan, Sathish Kumar Nimmya, Rajesh Kannan, Shibu George, Annex Edappattu, Nikhil K. Haridas, Wesley M. Jose, Pavithran Keechilat, Arun Valsan, Anoop Koshy, Rajesh Gopalakrishna, Shine Sadasivan, Unnikrishnan Gopalakrishnan, Dinesh Balakrishnan, Othiyil Vayoth Sudheer, Sudhindran Surendran. Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(5): 101404 doi: 10.1016/j.jceh.2024.101404
|
| 81 |
Xiaoxuan Liu, Lin Zhu, Jingjing Ma, Xinxiao Qiao, Dunwan Zhu, Lanxia Liu, Xigang Leng. Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptide. Drug Delivery and Translational Research 2017; 7(1): 147 doi: 10.1007/s13346-016-0348-1
|
| 82 |
Seung-Hun Kim, Wen-Hsing Wang, Jing-Ping Wang, Chang-Heng Hsieh, Kang Fang. Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 2018; 99: 997 doi: 10.1016/j.biopha.2018.01.157
|
| 83 |
Ali Alqahtani, Zubair Khan, Abdurahman Alloghbi, Tamer S. Said Ahmed, Mushtaq Ashraf, Danae M. Hammouda. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina 2019; 55(9): 526 doi: 10.3390/medicina55090526
|
| 84 |
Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry. Barriers to palliative care in hepatocellular carcinoma: A review of the literature. Journal of Gastroenterology and Hepatology 2023; 38(7): 1047 doi: 10.1111/jgh.16107
|
| 85 |
Juhua Zhuang, Saifei He, Guoyu Wang, Guangdong Wang, Jing Ni, Suiliang Zhang, Ying Ye, Wei Xia. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(8): 1257 doi: 10.3727/096504018X15172756878992
|
| 86 |
Peng Zhang, Jiang-Hua Zhao, Lin Chen, Zhao-Lian Bian, Lin-Ling Ju, Hui-Xuan Wang, Wei-Hua Cai. Expression and function of myelin expression factor 2 in hepatocellular carcinoma. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02644-3
|
| 87 |
Zhongqiang Qin, Fangquan Zhu, Bo Xie, Yang Zhang, Mu Yuan, Peipei Yang, Lan Zhang, Jianzhu Wei, Ziyi Zhu, Zhen Qian, Zhaoying Wang, Longfei Fan, Shuaishuai Xu, Yulin Tan, Jingyu Qian. Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma. Translational Oncology 2024; 39: 101816 doi: 10.1016/j.tranon.2023.101816
|
| 88 |
Zhihong Chen, Yiping Zou, Yuanpeng Zhang, Zhenrong Chen, Fan Wu, Ning Shi, Haosheng Jin. A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2021; 35(11) doi: 10.1002/jcla.24005
|
| 89 |
Xiao Liu, Chiying Xiao, Kunyan Yue, Min Chen, Hang Zhou, Xiaokai Yan. Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16341-w
|
| 90 |
Pei-Yi Chu, Shih-Hsuan Chan. Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma. Cancers 2021; 13(21): 5295 doi: 10.3390/cancers13215295
|
| 91 |
Juncheng Wei, Deyu Fang. Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Hepatocarcinoma. International Journal of Molecular Sciences 2021; 22(4): 1799 doi: 10.3390/ijms22041799
|
| 92 |
洪敬 刘. Advances in the Study of Micro-RNA inPrimary Liver Cancer. Advances in Clinical Medicine 2018; 8(10): 963 doi: 10.12677/ACM.2018.810160
|
| 93 |
Jiaying Du, Dongsheng Bai, Chunyang Gu, Jiawei Zhao, Chen Zhou, Yuxiang Wang, Yue Zhao, Na Lu. Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti-hepatocellular carcinoma efficacy. Oncogene 2024; 43(40): 3003 doi: 10.1038/s41388-024-03142-w
|
| 94 |
Jihan Huang, Feiyu Chen, Zhangfeng Zhong, Hor Yue Tan, Ning Wang, Yuting Liu, Xinyuan Fang, Tao Yang, Yibin Feng. Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00414
|
| 95 |
Dapeng Wu, Baiyang Zhu, Zonglong Nie, Qingnuan Kong, Wenjing Zhu. Establishment of the Prognostic Signature with Genes Related to G2/M Checkpoint in Hepatocellular Carcinoma. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10931-1
|
| 96 |
Jue Wang, Zongrui Jin, Guolin Wu, Jilong Wang, Banghao Xu, Hai Zhu, Ya Guo, Zhang Wen, Surendiran B. Bioinformatics Analysis for Constructing a Six-Immune-Related Long Noncoding RNA Signature as a Prognostic Model of Hepatocellular Carcinoma. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2093437
|
| 97 |
Xueying Wang, Yangyu Zhang, Na Yang, Hua He, Xuerong Tao, Changgui Kou, Jing Jiang. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5087643
|
| 98 |
Michael S Lee, Baek-Yeol Ryoo, Chih-Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P Hack, Jessica Spahn, Bo Liu, Heba Abdullah, Yulei Wang, Aiwu Ruth He, Kyung-Hun Lee, Y-J Bang, J Bendell, Y Chao, J-S Chen, H C Chung, S L Davis, A Dev, E Gane, B George, A R He, H Hochster, C-H Hsu, M Ikeda, J Lee, M Lee, A Mahipal, G Manji, M Morimoto, K Numata, M Pishvaian, S Qin, D Ryan, B-Y Ryoo, N Sasahira, S Stein, J Strickler, N Tebbutt. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. The Lancet Oncology 2020; 21(6): 808 doi: 10.1016/S1470-2045(20)30156-X
|
| 99 |
Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai-Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce Kah-Hoe Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut 2018; 67(10): 1845 doi: 10.1136/gutjnl-2017-315201
|
| 100 |
Vahid Mansouri, Nima Rezaei. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 1 doi: 10.1007/16833_2022_70
|
| 101 |
Tao Liu, Qiao Shi, Lei Yang, Shusen Wang, Hongli Song, Zhenglu Wang, Xinnv Xu, Hongsheng Liu, Hong Zheng, Zhongyang Shen. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08714-7
|
| 102 |
Jie Shen, Yu Zhou, Junpeng Pei, Dashuai Yang, Kailiang Zhao, Youming Ding. Development of prognostic models for advanced multiple hepatocellular carcinoma based on Cox regression, deep learning and machine learning algorithms. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1452188
|
| 103 |
Lun Wu, Jiao Zhou, Wenbo Zhou, Xue-Fei Huang, Qinhua Chen, Wei Wang, Lulu Zhai, Shengwei Li, Zhigang Tang. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo. Pathology - Research and Practice 2021; 220: 153270 doi: 10.1016/j.prp.2020.153270
|
| 104 |
Yih-Jyh Lin, Chia-Ni Lin, Tannaz Sedghi, Sylvia H. Hsu, Cary P. Gross, Jung-Der Wang, Shi-Yi Wang, Nader Hanna. Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan. PLOS ONE 2020; 15(10): e0240542 doi: 10.1371/journal.pone.0240542
|
| 105 |
Kangjun Zhang, Taishi Fang, Dong Zhao, Fulan Cen, Xu Yan, Xin Jin. Circular RNA Circ_0008043 promotes the proliferation and metastasis of hepatocellular carcinoma cells by regulating the microRNA (miR)-326/RAB21 axis. Bioengineered 2022; 13(3): 6600 doi: 10.1080/21655979.2022.2044260
|
| 106 |
Jeannette Huaman, Cuong Bach, Adeodat Ilboudo, Olorunseun O. Ogunwobi. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 131 doi: 10.1007/978-3-319-68082-8_8
|
| 107 |
Fat-Moon Suk, Chao-Lien Liu, Ming-Hua Hsu, Yu-Ting Chuang, Jack P. Wang, Yi-Jen Liao. Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53863-2
|
| 108 |
Bin Zhang, Yitao Liang, Liang Bo, Mingyu Chen, Bobo Huang, Qingpeng Cao, Jinwei Wei, Tianyu Li, Xiujun Cai, Xuesong Ye. A PCR-free screen-printed magnetic electrode for the detection of circular RNA from hepatocellular cancer based on a back-splice junction. RSC Advances 2021; 11(29): 17769 doi: 10.1039/D1RA01033F
|
| 109 |
Jelena Djokic Kovac, Tamara Milovanovic, Vladimir Dugalic, Igor Dumic. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(17): 2012-2029 doi: 10.3748/wjg.v26.i17.2012
|
| 110 |
Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jihye Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim. Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02210-3
|
| 111 |
Cheng Ean Chee, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Jian Yi Choy, Meibo Hu, Amrita Viswambaram, Han Chong Toh. Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore. Expert Review of Pharmacoeconomics & Outcomes Research 2024; 24(5): 631 doi: 10.1080/14737167.2024.2319607
|
| 112 |
Gokhan Yildiz. Integrated multi‑omics data analysis identifying novel drug sensitivity‑associated molecular targets of hepatocellular carcinoma cells. Oncology Letters 2018; doi: 10.3892/ol.2018.8634
|
| 113 |
Stefano Colagrande, Andrea Magnini, Lorenzo Cinci. Editorial for “Clinical‐Radiologic Morphology‐Radiomics Model on Gadobenate Dimeglumine‐Enhanced MRI for Identification of Highly Aggressive Hepatocellular Carcinoma: Temporal Validation and Multiscanner Validation”. Journal of Magnetic Resonance Imaging 2024; 60(6): 2655 doi: 10.1002/jmri.29328
|
| 114 |
Yuchuan Jiang, Peng Chen, Kaishun Hu, Guanqi Dai, Jinying Li, Dandan Zheng, Hui Yuan, Lu He, Penghui Xie, Mengxian Tu, Shuang Peng, Chen Qu, Wenyu Lin, Raymond T. Chung, Jian Hong. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation. Journal of Cellular and Molecular Medicine 2021; 25(3): 1568 doi: 10.1111/jcmm.16256
|
| 115 |
Bin Zhang, Mingyu Chen, Jiasheng Cao, Yitao Liang, Tingting Tu, Jiahao Hu, Tianyu Li, Yu Cai, Shijie Li, Boqiang Liu, Junjie Xu, Bo Liang, Xuesong Ye, Xiujun Cai. An integrated electrochemical POCT platform for ultrasensitive circRNA detection towards hepatocellular carcinoma diagnosis. Biosensors and Bioelectronics 2021; 192: 113500 doi: 10.1016/j.bios.2021.113500
|
| 116 |
Jasem Albarrak, Humaid Al-Shamsi. Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and Recommendations. Cancers 2023; 15(7): 2001 doi: 10.3390/cancers15072001
|
| 117 |
Langqing Sheng, Jiarong Li, Nianfeng Li, Liansheng Gong, Ling Liu, Qi Zhang, Xiaoli Li, Hui Luo, Zeguo Chen. Atractylenolide III predisposes miR‐195‐5p/FGFR1 signaling axis to exert tumor‐suppressive functions in liver cancer. Journal of Food Biochemistry 2021; 45(5) doi: 10.1111/jfbc.13582
|
| 118 |
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
|
| 119 |
Jiaying Wang, Yuting Miao, Lingmei Li, Yongqing Wu, Yan Ren, Yuehua Cui, Hongyan Cao. Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.962870
|
| 120 |
Guifu Xi, Runfen Cheng, Leiting Liang, Na Che, Yalei Wang, Nan Zhao, Xiaohui Liang, Bing Shao, Xiulan Zhao, Danfang Zhang. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32692-4
|
| 121 |
Jiuwei Zhang, Yaodong Chen, Jing Lin, Ruimei Jia, Tingting An, Tianxiu Dong, Yu Zhang, Xiuhua Yang. Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the EGFR-FAK-AKT/ERK1/2-Slug Signaling Pathway in Human Hepatocellular Carcinoma. DNA and Cell Biology 2020; 39(3): 355 doi: 10.1089/dna.2019.4990
|
| 122 |
Chen Zhou, Chunbao Sun, Wei Zhou, Tian Tian, Daniel C. Schultz, Tong Wu, Mu Yu, Lizi Wu, Liya Pi, Chenglong Li. Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. Journal of Medicinal Chemistry 2024; 67(18): 16270 doi: 10.1021/acs.jmedchem.4c00925
|